HealthLeap raises $30M Series A led by Hummingbird Ventures

HealthLeap Raises $30 Million Series A

San Francisco-based clinical AI company HealthLeap has raised a $30 million Series A round led by Hummingbird Ventures, according to funding data. The round was announced on October 7, 2026.

What HealthLeap Does

HealthLeap is a clinical AI platform that helps hospitals catch conditions that often go undiagnosed, starting with malnutrition. Plugged into the hospital EHR, it analyzes every adult inpatient record each day — labs, vitals, medications, and clinician notes — and pushes risk scores into care-team workflows so the highest-risk patients get reviewed first.

The company is extending the same screening approach to delirium, aspiration pneumonia, pressure injuries, and heart-failure readmissions.

Company Background

HealthLeap was co-founded in 2022 by siblings Josiah and Jemima Meyer and is headquartered in San Francisco. The company serves more than 50 hospitals.

Investors

The Series A was led by Hummingbird Ventures. Hummingbird Ventures was the only investor listed in the funding data for this round.

Why It Matters

HealthLeap's approach targets a persistent problem in hospital care: conditions that go undiagnosed because screening depends on manual review across large volumes of patient data. By analyzing every adult inpatient record daily and surfacing risk scores directly into care-team workflows, the platform aims to prioritize the patients most in need of review.

Starting with malnutrition gives the company a defined clinical entry point, and the planned expansion into delirium, aspiration pneumonia, pressure injuries, and heart-failure readmissions suggests a platform strategy across multiple screening use cases. Serving more than 50 hospitals indicates meaningful adoption within a few years of founding.

The Series A, led by Hummingbird Ventures, provides capital to extend the screening approach to additional conditions and to deepen hospital deployments.

What to Watch

• Progress extending screening beyond malnutrition to delirium, aspiration pneumonia, pressure injuries, and heart-failure readmissions
• Growth in the number of hospitals served beyond the current 50-plus
• How risk scores are integrated into care-team workflows across different EHR environments
• Whether Hummingbird Ventures' lead role brings additional operational or network support

Summary

HealthLeap, a San Francisco-based clinical AI platform founded in 2022 by siblings Josiah and Jemima Meyer, has raised a $30 million Series A led by Hummingbird Ventures. The company's platform analyzes every adult inpatient record daily via the hospital EHR and pushes risk scores into care-team workflows, starting with malnutrition and expanding to delirium, aspiration pneumonia, pressure injuries, and heart-failure readmissions. HealthLeap serves more than 50 hospitals.